The global Bioprocessing Equipment Market is witnessing robust growth, propelled by the surging demand for biologics and vaccines amid rising chronic diseases estimated at 1.8 billion adults with hypertension per WHO 2023 and the shift to continuous processing, which enhances yields by 20-30% and cuts costs 15-25% in monoclonal antibody (mAb) production, a segment dominating 45% of the market....